Solo International Provides Further Updates on Exploration and Acquisition

Solo International, Inc. "Solo International" or the "Company"), wishes to provide further exploration and acquisition updates.

Past work performed by the Company and as detailed in the recent NI43-101 geological report by the Company's consulting geologist, has identified Rare Earth Elements (REE) in the apatite mineralization with twelve anomalous values of Total Rare Earth Oxides (TREO) varying between 0.56% TREO and 0.08% TREO. The REE seem to be the highest ratio of Heavy REO to TREO.

Michel Plante comments: "We are pleased with what we believe to be encouraging results from the geological report and are excited to begin the planned upcoming work program to continue defining our property's mineralization and REE potential."

Solo International's plan is to engage in the phase one exploration program recommended by the Company's geologist team which will consist of a geophysical and mapping survey to determine suitable drill locations for the Company's following phase II drilling program.

It was also recommended that Solo International acquire additional claims in the surrounding area to extend the Company's current land holdings for further exploration.

We are pleased to report that we are currently in negotiations to acquire the surrounding properties as recommended in recent report.

Another highlight taken from our geological report prepared by Rémi Charbonneau, P.Geo., Ph.D., details:

"The discovery of many mine pits on the property reveals that the mineralization is more extensive than first considered in historic documents. It is possible and probable that many other mineralized zones are present on the property. "

Michel Plante
Chief Executive Officer and Director

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.